Guadagni F - Search Results

1

Redox Mechanisms in Migraine: Novel Therapeutics and Dietary Interventions.

Ferroni P, Barbanti P, Della-Morte D, Palmirotta R, Jirillo E, Guadagni F. Ferroni P, et al. Among authors: guadagni f. Antioxid Redox Signal. 2018 Apr 20;28(12):1144-1183. doi: 10.1089/ars.2017.7260. Epub 2017 Nov 21. Antioxid Redox Signal. 2018. PMID: 28990418 Review.

2

Clinical evaluation of the new tumor marker TAG-72.

Guadagni F, Roselli M, Ferroni P, Amato T, Colcher D, Greiner JW, Schlom J. Guadagni F, et al. Anticancer Res. 1991 Jul-Aug;11(4):1389-94. Anticancer Res. 1991. PMID: 1746895

3

CA 72-4 serum marker--a new tool in the management of carcinoma patients.

Guadagni F, Roselli M, Cosimelli M, Ferroni P, Spila A, Cavaliere F, Casaldi V, Wappner G, Abbolito MR, Greiner JW, et al. Guadagni F, et al. Cancer Invest. 1995;13(2):227-38. doi: 10.3109/07357909509011692. Cancer Invest. 1995. PMID: 7874576 Review.

4

Evaluation of tumor-associated glycoprotein-72 and CA 125 serum markers in patients with gynecologic diseases.

Guadagni F, Marth C, Zeimet AG, Ferroni P, Spila A, Abbolito R, Roselli M, Greiner JW, Schlom J. Guadagni F, et al. Am J Obstet Gynecol. 1994 Nov;171(5):1183-91. doi: 10.1016/0002-9378(94)90129-5. Am J Obstet Gynecol. 1994. PMID: 7977516

5

Evaluation of the potential role of class II histocompatibility antigen HLA-DR in platelet/tumor cell interaction.

Ferroni P, Guadagni F, Spila A, Martini F, Gazzaniga PP. Ferroni P, et al. Among authors: guadagni f. Cancer Res. 1994 Feb 1;54(3):623-5. Cancer Res. 1994. PMID: 8306320

6

Platelet proaggregating activity of human colorectal tumour cell lines does not correlate with the degree of differentiation.

Ferroni P, Guadagni F, Pavan A, Martinico E, Torrisi MR, Gazzaniga PP. Ferroni P, et al. Among authors: guadagni f. Eur J Cancer. 1993;29A(7):1028-33. doi: 10.1016/s0959-8049(05)80217-5. Eur J Cancer. 1993. PMID: 8499133

7

Tumor markers as targets for selective diagnostic and therapeutic procedures.

Roselli M, Guadagni F, Buonomo O, Belardi A, Ferroni P, Diodati A, Anselmi D, Cipriani C, Casciani CU, Greiner J, Schlom J. Roselli M, et al. Among authors: guadagni f. Anticancer Res. 1996 Jul-Aug;16(4B):2187-92. Anticancer Res. 1996. PMID: 8694541 Review.

8

Clinical utility of CA 72-4 serum marker in the staging and immediate post-surgical management of gastric cancer patients.

Spila A, Roselli M, Cosimelli M, Ferroni P, Cavaliere F, Arcuri R, Tedesco M, Carlini S, D'Alessandro R, Perri P, Casciani CU, Greiner JW, Schlom J, Guadagni F. Spila A, et al. Among authors: guadagni f. Anticancer Res. 1996 Jul-Aug;16(4B):2241-7. Anticancer Res. 1996. PMID: 8694550

9

CA 19-9 monosialoganglioside content of human colorectal tumor cells correlates with tumor cell-induced platelet aggregation.

Martini F, Guadagni F, Lenti L, D'Alessandro R, Aloe S, Roselli M, Gazzaniga PP, Ferroni P. Martini F, et al. Among authors: guadagni f. Anticancer Res. 2000 May-Jun;20(3A):1609-14. Anticancer Res. 2000. PMID: 10928079

10

Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancer.

D'Alessandro R, Roselli M, Ferroni P, Mariotti S, Spila A, Aloe S, Carone MD, Abbolito MR, Carlini S, Perri P, Ricciotti A, Botti C, Conti F, Vici P, Chiappetta NR, Cognetti F, Buonomo O, Guadagni F. D'Alessandro R, et al. Among authors: guadagni f. Breast Cancer Res Treat. 2001 Jul;68(1):9-19. doi: 10.1023/a:1017903724176. Breast Cancer Res Treat. 2001. PMID: 11678313

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

263 results

Search Page